SCHEMBL24570929

SCHEMBL24570929

CC1CCN(C2CCc3cc(Br)ccc32)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.42
CCR5 P51681 1/20 0.39
OPRM1 P35372 3/20 0.35
OPRD1 P41143 2/20 0.35
OPRK1 P41145 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
KDM4E B2RXH2 1/20 0.34
SLC6A4 P31645 1/20 0.34
DRD2 P14416 2/20 0.33
DRD1 P21728 2/20 0.33
DRD4 P21917 2/20 0.33
DRD5 P21918 2/20 0.33
DRD3 P35462 2/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
CXCR3 P49682 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31158034 0.91 SRD5A1 (0.44) SRD5A1CCR5OPRM1OPRD1OPRK1
SCHEMBL24570919 0.91 SRD5A1 (0.44) SRD5A1CCR5OPRM1OPRD1OPRK1
SCHEMBL2572477 0.82 SRD5A1 (0.40) SRD5A1CCR5
SCHEMBL12039615 0.82 SRD5A1 (0.40) SRD5A1CCR5
SCHEMBL2572769 0.81 SRD5A1 (0.48) SRD5A1CCR5OPRM1OPRD1OPRK1
SCHEMBL2571011 0.81 SRD5A1 (0.48) SRD5A1CCR5OPRM1OPRD1OPRK1
SCHEMBL2571280 0.81 SRD5A1 (0.48) SRD5A1CCR5OPRM1OPRD1OPRK1
SCHEMBL3866433 0.80 CHRNA7 (0.46) SRD5A1OPRM1OPRD1OPRK1
SCHEMBL31158032 0.80 SRD5A1 (0.42) SRD5A1CCR5OPRM1OPRD1OPRK1
SCHEMBL30584424 0.80 NOTUM (0.42) SRD5A1CCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140555-A1 CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2022-06-30 WO disclosed